Related Experiment Video

Updated: Apr 5, 2026

Author Spotlight: Advancing In Vitro Blood Cell Production with Single-Cell Multiomics and Functional Genomics
04:11

Author Spotlight: Advancing In Vitro Blood Cell Production with Single-Cell Multiomics and Functional Genomics

Published on: March 15, 2024

1.8K

Phenobarbital and Phototherapy Combination Enhances Decline of Total Serum Bilirubin and May Decrease the Need for

Mahmoud Af Kaabneh1, Ghassan Sa Salama1, Ayoub Ga Shakkoury1

  • 1Pediatric Department, Royal Medical Services, Amman, Jordan.

Clinical Medicine Insights. Pediatrics
|August 27, 2015
PubMed

Insights

Phenobarbital combined with phototherapy significantly reduces total serum bilirubin in newborn infants with isoimmune hemolytic disease (IHD). This combination therapy decreases the need for blood exchange transfusions compared to phototherapy alone.

Area of Science:

  • Neonatal Medicine
  • Pediatric Hematology
  • Pharmacology

Background:

  • Neonatal jaundice, particularly in isoimmune hemolytic disease (IHD), poses significant health risks.
  • Effective management strategies are crucial to prevent severe hyperbilirubinemia and its complications.
  • Blood exchange transfusion is an established but invasive treatment for severe cases.

Purpose of the Study:

  • To evaluate the efficacy of phenobarbital combined with phototherapy in treating neonatal IHD.
  • To assess the impact of this combination therapy on total serum bilirubin levels.
  • To determine if this approach reduces the rate of blood exchange transfusions.

Main Methods:

  • A single-blinded, prospective, randomized controlled trial involving 200 neonates with IHD.
  • Infants were randomized into two groups: phenobarbital plus phototherapy (n=103) and phototherapy alone (n=97).
  • Phenobarbital (2.5 mg/kg every 12 hours for 3 days) was administered orally to the intervention group.

Main Results:

  • A statistically significant difference in mean total serum bilirubin levels was observed at 24, 48, and 72 hours between the groups (P < 0.05).
  • The phenobarbital plus phototherapy group showed a faster decline in bilirubin levels.
  • Fewer infants in the combination group required blood exchange transfusion (7 vs. 15, P = 0.0478).

Conclusions:

  • Phenobarbital in conjunction with phototherapy is an effective strategy for managing neonatal IHD.
  • This combination therapy leads to a more rapid reduction in total serum bilirubin.
  • The use of phenobarbital may decrease the necessity for blood exchange transfusions in resource-limited settings.
Abstract

Keywords:
hyperbilirubinemiaphenobarbitalphototherapy

More Related Videos

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia08:47

The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia

Published on: November 19, 2008

36.5K
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy10:30

A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy

Published on: May 16, 2015

20.4K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
337
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
750
Sedatives and Hypnotics Drugs: Barbiturates01:20

Sedatives and Hypnotics Drugs: Barbiturates

Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
1.4K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
804
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
897
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
482